Mate I've held a similar 'gut feel' viewpoint for some time. I simply cannot believe no large pharma has seen what's happening here with the P2 trial results in 2591 and not expressed an interest. My feeling is that our so-called pileline-in-a-drug NNZ 2591 is potentially worth so much, that what might seem a reasonable premium right now, would be selling the farm for a song in terms of future value. My feeling is that JP and co have quietly, and respectfully told anyone sniffing around with talk of 'reasonable' offers to come back in a year or two with a few extra zeros. IMO only of course. GLA.
NEU Price at posting:
$13.17 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)